Archive for May, 2021
“Dual-Channel Policy” for Medicines under National Medical Insurance Negotiation
Recently, the NMPA and the National Health Commission jointly issued the “Opinions on Establishing and Improving Dual-Channel Management Mechanisms for Medicines under National Medical Insurance Negotiation”. According to the “Opinions”, the reasonable usage of these reimbursed drugs, such as supply and clinical use, will be met through two channels, namely designated medical institutions and designated retail pharmacies, with drug payment covered by the medical insurance payment mechanism. Eligible designated retailed pharmacies should be connected to the Medical Insurance Information Platform and the Electronic Prescription Sharing Platform, and a compliant storage and distribution system should be established to ensure drug safety.
医保药品可“双通道”购买
来源：中华人民共和国中央人民政府 2021.05.11
近期，国家医保局会同国家卫健委出台了《关于建立完善国家医保谈判药品“双通道”管理机制的指导意见》。《意见》提出，将通过定点医疗机构和定点零售药店两个渠道满足医保谈判药品供应保障、临床使用等方面的合理需求，并同步纳入医保支付；符合纳入“双通道”管理的定点零售药店要与医保信息平台、电子处方流转平台等对接，并建立符合要求的储存、配送体系，确保药品质量安全。
The State Council: establishing a national drug traceability collaboration platform
Recently, the State Council issued the “Opinions on Strengthening Drug Supervising Capacity.” The “Opinion” stipulates that the traceability information system be enhanced and a national drug traceability collaboration platform be established to achieve complete drug tracking and tracing and to gradually apply unique identification for medical devices.
国办：构建全国药品追溯协同平台，实现全周期追溯
来源：医药网 2021.05.11
日前，国务院办公厅印发《关于全面加强药品监管能力建设的实施意见》。《实施意见》提出，应完善信息化追溯体系，构建全国药品追溯协同平台，实现药品全生命周期追溯，逐步实施医疗器械唯一标识。